Health, Grassi (Gsk): “Against Lupus, Belimumab effective and safe garrison”

Barbara Grassi, Vp scientific medical director Gsk, spoke during the meeting “When lupus attacks the kidney”, held in Rome on Monday 30 January, explaining that in ten years of study the monoclonal antibody belimumab has proven to be an effective and safe as an adjunct to standard therapy to combat lupus nephritis.